본문 바로가기
KERD
논문KCI 등재

바이오의약품 사고로 인한 피해구제법리 - 제조물책임법리를 중심으로 -

Legal principals concerning relief schemes for Adverse Biomedicine Reaction

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류법학

초록

Humankind history is faced with one gigantic turning point due to development of genetically modified organisms. Food production by means of GMO is on the acceleration in an effort to solve the shortage of food problems. Food is also used as alternative energy source. Use of GMO product is not only limited to food and energy, but is actively utilized in various fields of medicines. This paper is first to check out the state of biomedicine developed and associated problems from industries that use GMO, after which we made an attempt on legislative approach to find out means of relief,through examples of such laws legislated for the sufferer from the adverse effect of the biomedicine. As for the liable subject to bear the responsibility for compensatory damage in a way of relieving the victim owing to adverse effect of biomedicine, those who manufactured and sold biomedicine and who are related to the damage to the victim due to the accident and medical doctors and pharmacists who prescribe and administer the medicine in question have been looked into. Accidents involving medicines and medical supplies could take place without reason for imputation on part of the liable subjects or fault of the victim, in which case the victim can’t receive damage compensation from any of both parties. When such accidents happened turn out to be no fault accidents, introduction of damage relief measures might have to be reviewed against side effects of medicine and medical supplies as no fault compensation in order for actual relief to be possible. Talking about technicality of legislation, we can suggest a method of strengthening the accountability of manufacturer for stereotypical agenda on biomedicines by newly legislating special regulation with an issue that resists claim on risks associated with the development of medicine and incorporating the same into Manufactured Product Liability Law. After all, when an accident happens associated with biomedicine, the damage will be done to the consumer. And the consumer will be exposed to fatal danger even without the time to cope with potential risks associated with medicine and medical supplies they take. Therefore, it is necessary to protect the potential victim by having the manufacturer of biomedicines bear the liability of medical risks.

Abstract

Humankind history is faced with one gigantic turning point due to development of genetically modified organisms. Food production by means of GMO is on the acceleration in an effort to solve the shortage of food problems. Food is also used as alternative energy source. Use of GMO product is not only limited to food and energy, but is actively utilized in various fields of medicines. This paper is first to check out the state of biomedicine developed and associated problems from industries that use GMO, after which we made an attempt on legislative approach to find out means of relief,through examples of such laws legislated for the sufferer from the adverse effect of the biomedicine. As for the liable subject to bear the responsibility for compensatory damage in a way of relieving the victim owing to adverse effect of biomedicine, those who manufactured and sold biomedicine and who are related to the damage to the victim due to the accident and medical doctors and pharmacists who prescribe and administer the medicine in question have been looked into. Accidents involving medicines and medical supplies could take place without reason for imputation on part of the liable subjects or fault of the victim, in which case the victim can’t receive damage compensation from any of both parties. When such accidents happened turn out to be no fault accidents, introduction of damage relief measures might have to be reviewed against side effects of medicine and medical supplies as no fault compensation in order for actual relief to be possible. Talking about technicality of legislation, we can suggest a method of strengthening the accountability of manufacturer for stereotypical agenda on biomedicines by newly legislating special regulation with an issue that resists claim on risks associated with the development of medicine and incorporating the same into Manufactured Product Liability Law. After all, when an accident happens associated with biomedicine, the damage will be done to the consumer. And the consumer will be exposed to fatal danger even without the time to cope with potential risks associated with medicine and medical supplies they take. Therefore, it is necessary to protect the potential victim by having the manufacturer of biomedicines bear the liability of medical risks.

참고문헌 (39)

  1. 김천수, "대체의약품과 약사법", 의료법학, 5(1) (2004), 대한의료법학회
  2. 전병남, "의약품사고의 민사책임에 관한 연구", 박사, pp.2005
  3. 약화사고의 규모파악과 예방대책에 대한 정책연구, 국정감사 정책자료집, "정화원", 6~ (2006)
  4. 전병남, "의약품사고로 인한 책임경합-의약품제조업자ㆍ의사ㆍ국가간의 책임경합을 중심으로-", 의료법학, 7(1) (2006), 대한의료법학회
  5. 고은지, "기로에 선 국내 바이오산업", LG 주간경제, pp.21~25 (2007)
  6. 조정숙, "바이오산업과 GMO", BIOSAFETY, 10(2) (2009), 한국바이오안정성정보센터
  7. 한국생명공학연구원, "2008바이오안전성백서" (2008), 한국생명공학연구원 바이오안정성정보센터
  8. 문상혁, "유전자변형생물체에 관한 법적 규제와 손해배상책임", 박사, pp.2009
  9. Gregory D.S.Kim, "선진국 사례중심으로 본 제조물책임(PL)법", pp.240~243
  10. 稻垣 喬, "醫療過誤訴訟の理論", pp.141~ (1985), 日本評論社
  11. 강봉석, "유전공학에서의 손해배상책임", 환경법연구, 24(1) (2002), 환경법학회
  12. 김상용, "불법행위법" (1997), 법문사
  13. 윤용석, "서독 불법행위법상의 소위 Verkehrspflicht에 관한 고찰", 법학연구, 27(1), pp.12~ (1984), 부산대학교
  14. 윤석찬, "혈액사고의 책임문제와 그 해결방안에 관한 연구 - 감염된 혈액제제 제조업자의 책임을 중심으로 -", 비교사법, 14(3), pp.471~504 (2007), 한국비교사법학회
  15. 김민동, "의약품의 설계상 결함으로 인한 제조물책임 - 미국의 리스테이트먼트와 판례이론을 중심으로", 고려법학, (56), pp.95~136 (2010), 법학연구원
  16. 전경운, "환경사법론, 아산재단 연구보고서 제120집" (2009), 집문당
  17. Erwin Deutsch, "유전공학법상의 책임과 권리보호, in 법정논총 제9권", pp.108~ (1991), 대구대학교출판부
  18. 전병남, "제조물책임법상 제조물로서의 의약품의 개념", 의료법학, 7(2) (2006), 대한의료법학회
  19. 이상정, "제조물책임법 제정의 의의와 향후 과제", 저스티스, 통권 : 68, pp.8~ (2002)
  20. 안법영, "의료와 제조물책임, 제14기 의료법학연구과정 교재" (2002), 고려대학교 의사법연구소
  21. 朝見行弘, "製造者の責任と非製造者の責任, in 新ㆍ現代損害賠償法講座 3", pp.136~ (1997), 日本評論社
  22. 제조물책임에서의 제조물과 결함의 개념, 디지털 시대의 소비자보호와 법Ⅱ-전자상거래와 제조물책임-, "권대우", 한국법제연구원, 17~ (2002)
  23. 김천수, "제조물책임법상 제조물의 개념", 성균관법학, 16(1), pp.35~66 (2004), 법학연구소
  24. 김천수, "의료제조물책임법, 제16기 의료법학고위과정 교재", pp.29~ (2005), 고려대학교 의사법학연구소
  25. 김제완, "제약산업과 제조물책임연구논문", 사법, 1(2), pp.3~42 (2007), 사법발전재단
  26. 전병남, "감기약 콘택600 제조물책임사건에 관한 민사법적 고찰 -대법원 2008.2.28. 선고 2007다52287 판결", 의료법학, 10(1), pp.213~260 (2009), 대한의료법학회
  27. 山口浩一郞, "醫藥品製造者の損害賠償責任, in 現代損害賠償法講座 4", pp.459~ (1974), 日本評論社
  28. 약화사고의 책임, 12기 의료법학연구과정자료, "김형배", 고려대학교 의사법연구소, 6~ (2002)
  29. 김선중, "의료과 오소송법", pp.228~ (2005), 박영사
  30. 이은영, "채권각론" (2007), 박영사
  31. 문상혁, "제조물책임법에 관한 연구", 석사, pp.2002
  32. 권오승, "의료과오와 의사의 주의의무", 민사판례연구, 4, pp.96~ (1993), 민사판례연구회
  33. 안법영, "산부인과 진료와 의사의 주의의무", 의료법학, pp.59~ (2000), 대한의료법학회
  34. 권용우, "약화사고의 책임", 법학논총, 20 (1994), 단국대학교 법학연구소
  35. 윤석찬, "독일의 의약품법과 민사책임", 법학연구, 47(1) (2006), 부산대학교
  36. 강봉석, "의약품사고에 있어서의 손해배상책임", 법학논집, 4(3), pp.106~ (1999), 이화여자대학교 법학연구소
  37. 전현희, "약사법의 의료법학적 검토", 의료법학, 2(1), pp.125~, 대한의료법학회
  38. 안법영, "독일 의약품법과 제조물책임법-결함있는 의약품에 대한 제조물책임법의 적용을 위한 소고-", 의료법학, 3(2), pp.150~ (2002)
  39. 윤석찬, "독일에서의 의사의 민사책임의 새로운 발전", 재산법연구, 21(1), pp.221~241 (2004), 한국재산법학회

관련 논문AI추천

이 간행물의 다른 논문 (42건)